Lexaria Bioscience (NASDAQ: LEXX)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-14 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.250 | ||||||
REV | 30.650K |
You can purchase shares of Lexaria Bioscience (NASDAQ: LEXX) through any online brokerage.
Other companies in Lexaria Bioscience’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Cumberland (NASDAQ:CPIX), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
There is no analysis for Lexaria Bioscience
The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $3.22 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for Lexaria Bioscience.
Lexaria Bioscience’s Q3 earnings are confirmed for Thursday, July 14, 2022.
There is no upcoming split for Lexaria Bioscience.
Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.